181 related articles for article (PubMed ID: 23267813)
1. Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantation.
Waterhouse M; Duque-Afonso J; Wäsch R; Bertz H; Finke J
Transplant Proc; 2013; 45(1):397-401. PubMed ID: 23267813
[TBL] [Abstract][Full Text] [Related]
2. The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis.
Chiusolo P; Bellesi S; Piccirillo N; Giammarco S; Marietti S; De Ritis D; Metafuni E; Stignani M; Baricordi OR; Sica S; Leone G; Rizzo R
Bone Marrow Transplant; 2012 Jan; 47(1):120-4. PubMed ID: 21399669
[TBL] [Abstract][Full Text] [Related]
3. Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versus-host disease.
Liu H; Chen Y; Xuan L; Wu X; Zhang Y; Fan Z; Huang F; Zhang X; Jiang Q; Sun J; Liu Q
Acta Haematol; 2013; 130(3):160-8. PubMed ID: 23711991
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
Kobos R; Steinherz PG; Kernan NA; Prockop SE; Scaradavou A; Small TN; Shukla N; Khalaf R; O'Reilly RJ; Boulad F
Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789
[TBL] [Abstract][Full Text] [Related]
6. Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes.
Littera R; Piredda G; Pani A; Frongia M; Onano B; Michittu MB; Murgia MG; Lai S; Alba F; Valentini MD; Loi V; Caocci G; Orrù S; La Nasa G; Carcassi C
J Nephrol; 2013; 26(6):1170-8. PubMed ID: 23475463
[TBL] [Abstract][Full Text] [Related]
7. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
8. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
Kordelas L; Schwich E; Lindemann M; Heinemann FM; Buttkereit U; Horn PA; Beelen DW; Rebmann V
Front Immunol; 2019; 10():3027. PubMed ID: 31998310
[TBL] [Abstract][Full Text] [Related]
9. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.
Mohty M; Labopin M; Balère ML; Socié G; Milpied N; Tabrizi R; Ifrah N; Hicheri Y; Dhedin N; Michallet M; Buzyn A; Cahn JY; Bourhis JH; Blaise D; Raffoux C; Espérou H; Yakoub-Agha I
Leukemia; 2010 Nov; 24(11):1867-74. PubMed ID: 20882046
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-G 3' untranslated region polymorphisms are associated with better kidney allograft acceptance.
Cilião Alves DC; de Oliveira Crispim JC; Castelli EC; Mendes-Junior CT; Deghaide NH; Barros Silva GE; Costa RS; Saber LT; Moreau P; Donadi EA
Hum Immunol; 2012 Jan; 73(1):52-9. PubMed ID: 22044721
[TBL] [Abstract][Full Text] [Related]
11. Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT.
Mo XD; Xu LP; Liu DH; Chen YH; Han W; Zhang XH; Chen H; Wang Y; Wang JZ; Liu KY; Huang XJ
Bone Marrow Transplant; 2012 Sep; 47(9):1201-5. PubMed ID: 22231459
[TBL] [Abstract][Full Text] [Related]
12. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
Kanga U; Mourya M; Seth T; George J; Sood P; Sharma R; Saxena A; Mehra NK
Transplant Proc; 2012 May; 44(4):919-21. PubMed ID: 22564585
[TBL] [Abstract][Full Text] [Related]
13. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
14. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
Hosseini E; Schwarer AP; Ghasemzadeh M
Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
[TBL] [Abstract][Full Text] [Related]
15. RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.
Shin DY; Kim I; Kim JH; Lee YG; Kang EJ; Cho HJ; Lee KH; Kim HJ; Park EH; Lee JE; Bae JY; See CJ; Yoon SS; Park SS; Han KS; Park MH; Hong YC; Park S; Kim BK
Acta Haematol; 2013; 129(3):137-45. PubMed ID: 23207898
[TBL] [Abstract][Full Text] [Related]
16. Genotypes and haplotypes in the 3' untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia.
Sizzano F; Testi M; Zito L; Crocchiolo R; Troiano M; Mazzi B; Turchiano G; Torchio M; Pultrone C; Gregori S; Chiesa R; Gaziev J; Sodani P; Marktel S; Amoroso A; Roncarolo MG; Lucarelli G; Ciceri F; Andreani M; Fleischhauer K
Tissue Antigens; 2012 May; 79(5):326-32. PubMed ID: 22489942
[TBL] [Abstract][Full Text] [Related]
17. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
18. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.
Nomura S; Ito T; Katayama Y; Ota S; Hayashi K; Fujita S; Satake A; Ishii K
Transpl Immunol; 2019 Apr; 53():28-33. PubMed ID: 30543860
[TBL] [Abstract][Full Text] [Related]
20. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.
Bettens F; Passweg J; Schanz U; Chalandon Y; Heim D; Güngör T; Stussi G; Nicoloso G; Baldomero H; Gratwohl A; Tiercy JM
Biol Blood Marrow Transplant; 2012 Apr; 18(4):608-16. PubMed ID: 21963878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
